Advanced pancreatic ductal adenocarcinoma - Complexities of treatment and emerging therapeutic options
Pancreatic ductal adenocarcinoma is a devastating disease with a poor prognosis regardless of stage. To date the mainstay of therapy for advanced disease has been chemotherapy with little incremental improvements in outcome. Despite extensive research investigating new treatment options the current practices continue to utilise fluorouracil or gemcitabine containing combinations. The need for novel therapeutic approaches is mandated by the ongoing poor survival rates associated with this...[Show more]
|Collections||ANU Research Publications|
|Source:||World Journal of Gastroenterology|
Items in Open Research are protected by copyright, with all rights reserved, unless otherwise indicated.